C1822578||Response Monitoring
C0006826||Cancer
C0281318||Antiangiogenesis Therapy
C2986496||Noninvasive
C0032743||PET Molecular Imaging
C1837655||Multifactorial
C0281318||Antiangiogenesis therapy
C0281318||Antiangiogenesis therapy
C1527144||therapeutic effects
C0006826||cancer
C0281318||Antiangiogenesis therapy
C1822578||response monitoring
C0281318||Antiangiogenesis therapy
C0596087||anti-angiogenic drug
C1176020||sunitinib
C0027651||U87MG tumors
C2986496||noninvasive
C1699633||positron emission computed tomography (PET) molecular imaging
C1837655||multifactorial
C0027651||U87MG tumor
C0025929||mice
C0442113||intragastric
C0021485||injections
C1176020||sunitinib
C0042444||vehicle
C0205127||Longitudinal
C1699633||MicroPET/CT scans
C0046056||(18)F-FDG
C3661419||(18)F-FMISO,
C2700345||(18)F-ML-10
C3852643||(18)F-Alfatide II
C0025519||metabolism
C0242184||hypoxia
C0162638||apoptosis
C1519670||angiogenesis
C0087111||therapy
C0475358||Tumor tissues
C0025929||mice
C0041365||biomarkers
C1527589||Glut-1
C2351139||CA-IX
C1138427||ανβ3
C0081939||CD31
C1699633||PET imaging
C0475440||tumor sizes
C0025929||mouse
C0027651||tumor
C0243144||uptake
C0027651||tumor
C0026845||muscle
C0027651||T
C0026845||M
C1176020||Sunitinib
C0475440||tumor size
C1176020||sunitinib
C1533734||treatment
C0243144||uptakes
C3661419||(18)F-FMISO
C0242184||hypoxia
C2700345||(18)F-ML-10
C0162638||apoptosis
C3852643||(18)F-Alfatide II
C1519670||angiogenesis
C0027651||tumor
C0221198||lesions
C1176020||sunitinib
C1533734||treatment
C0243144||uptake
C0046056||(18)F-FDG
C0596620||glucose metabolism
C1699633||PET imaging
C0041365||biomarkers
C1699633||PET imaging
C3852643||(18)F-Alfatide II
C3661419||(18)F-FMISO
C0046056||(18)F-FDG
C2700345||(18)F-ML-10
C0027651||tumor
C0243144||uptake
C1699633||positron emission computed tomography
C3852643||(18)F-Alfatide II
C1699633||positron emission computed tomography
C1822578||response
C0596087||anti-angiogenic drug
C1176020||sunitinib
C0027651||U87MG tumors
C1822578||response monitoring
C0006826||cancer
C0281318||Antiangiogenesis therapy
C2986496||noninvasive
C0032743||PET molecular imaging
C1837655||multifactorial
C1519670||angiogenesis
C0011923||imaging
C3852643||(18)F-Alfatide II
C0052350||RGD